Brello Health advertises all-inclusive pricing for compounded GLP-1 medication, but the prepaid structure and renewal timing create cost-transparency questions that matter at the point of decision.

Trava does not publish itemized semaglutide pricing, plan structures, or renewal rates on its website. Verification attempts through September 2026 found no stable public figures, requiring direct intake for a quote.

Hims & Hers bundles visits, labs, and shipping into one advertised price, but the $1,194 upfront commitment for compounded semaglutide may surprise consumers expecting true monthly billing.

Trava does not publish itemized pricing for its compounded GLP-1 program. This analysis explains what is known, what remains unclear, and how to evaluate alternatives with transparent, checkout-verified rates.

Zealthy advertises compounded semaglutide from $151 monthly when paid quarterly, but the upfront total and membership fees remain undisclosed on public pages. PlexusDx lists transparent month-to-month and prepaid rates with no hidden membership.

BetterMe Rx does not publish semaglutide pricing publicly and had not been checkout-verified as of July 2026. This article explains what we know, what remains unknown, and how that uncertainty affects cost comparison decisions.